BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 27916654)

  • 1. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
    Hasegawa M; Nonaka T; Masuda-Suzukake M
    Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
    Nonaka T
    Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
    Tarutani A; Hisanaga SI; Hasegawa M
    Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions.
    Condello C; Ayers JI; Dalgard CL; Garcia Garcia MM; Rivera BM; Seeley WW; Perl DP; Prusiner SB
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2220984120. PubMed ID: 36952379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are neurodegenerative diseases "protein cancers"?].
    Hasegawa M
    Brain Nerve; 2012 Jun; 64(6):675-9. PubMed ID: 22647475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
    Vargas JY; Grudina C; Zurzolo C
    Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
    Goedert M; Masuda-Suzukake M; Falcon B
    Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
    Tarutani A; Adachi T; Akatsu H; Hashizume Y; Hasegawa K; Saito Y; Robinson AC; Mann DMA; Yoshida M; Murayama S; Hasegawa M
    Acta Neuropathol; 2022 Jun; 143(6):613-640. PubMed ID: 35513543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases.
    Hu C; Yan Y; Jin Y; Yang J; Xi Y; Zhong Z
    Neurosci Bull; 2024 Feb; 40(2):241-254. PubMed ID: 37755677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
    Braak H; Del Tredici K
    Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental models of prion-like protein propagation.
    Hasegawa M
    Neuropathology; 2020 Oct; 40(5):460-466. PubMed ID: 32478452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-like properties of assembled TDP-43.
    Nonaka T; Hasegawa M
    Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.